Table 6.
Variables | B | Wald X2 | P value | OR | 95% CI |
---|---|---|---|---|---|
Gender | 0.538 | 6.076 | 0.014 | 1.713 | 1.117–2.628 |
Smoking status | − 0.586 | 6.690 | 0.010 | 0.557 | 0.357–0.868 |
Lepidic predominant$ | 0.493 | 1.495 | 0.221 | 1.637 | 0.743–3.609 |
lymphatic metastasis | − 0.189 | 0.993 | 0.319 | 1.208 | 0.833–1.751 |
maximum diameter | 0.000 | 0.003 | 0.957 | 1.000 | 0.989–1.012 |
Type | − 0.188 | 0.271 | 0.603 | 0.829 | 0.408–1.683 |
Texture | 1.110 | 18.935 | 0.000 | 3.035 | 1.841–5.004 |
Air bronchograms | 0.648 | 12.566 | 0.000 | 1.912 | 1.336–2.737 |
Margin | 0.062 | 0.104 | 0.747 | 1.063 | 0.732–1.545 |
Pleural retraction | 0.781 | 20.502 | 0.000 | 2.183 | 1.557–3.061 |
lymphadenopathy | − 0.307 | 2.005 | 0.157 | 0.736 | 0.481–1.125 |
OR odds ratio; CI confidence interval.
$Lepidic predominant includes adenocarcinoma in situ, minimally invasive adenocarcinoma, and lepidic predominant invasive adenocarcinoma.